JMAR Competitively Selected by U.S. Army for Phase II SBIR Grant; Work Focuses on Development of New Laser for Remote Detection of Improvised Explosive Devices (IEDs)

SAN DIEGO--(BUSINESS WIRE)--June 13, 2006--JMAR Technologies, Inc. (NASDAQ: JMAR), a leading innovator in the development of laser-based technology and x-ray processes for imaging, analysis and fabrication at the nanoscale, announced that the Company has been competitively selected for the award of a Phase II SBIR grant by the U.S. Army to conduct research leading to the development of a compact, double pulse laser system capable of real-time spectrochemical hazard analysis in the field. This new detection approach is based on JMAR's proven BriteLight(TM) technology and offers an improved method of detecting hazardous materials from safe, remote locations.

Taking advantage of BriteLight's unique combination of excellent spatial beam quality and high pulse energy, this new laser will be specially designed for adjustable, double-pulse mode operation to support laser-induced breakdown spectroscopy (LIBS). LIBS techniques are well suited to field analysis because only the laser beam must reach the sample, allowing remote monitoring of hazardous materials or materials situated in difficult to reach locations.

“We are very pleased with this opportunity to continue our support of the U.S. Army by adapting our modular BriteLight laser to handle remote, non-contact detection of hazardous materials”

The DOD Small Business Innovative Research (SBIR) program was developed to stimulate technological innovation to meet military as well as commercial needs. During Phase I, JMAR accomplished feasibility studies and proof of concept. This selection for Phase II will result in two prototypes--a small man-portable LIBS unit and a larger vehicle-portable version. The Phase II contract amount is expected to be $750,000.

"We are very pleased with this opportunity to continue our support of the U.S. Army by adapting our modular BriteLight laser to handle remote, non-contact detection of hazardous materials," commented C. Neil Beer, President and CEO of JMAR. "This protective use of our core technology by the military will also lead to several exciting commercial applications."

About BriteLight(TM)

JMAR's BriteLight(TM) Modular Solid State Laser System provides a unique combination of high brightness, short pulse duration, and exceptional beam quality in a modular, compact design. The product also offers research scientists and manufacturing engineers a versatile laser source that can be used for a multitude of applications, including spectrochemical analysis, nanotech scale fabrication, microscopy and soft x-ray source generation.

About JMAR

JMAR Technologies, Inc. is a leading innovator in the development of laser-based technology for imaging, analysis and fabrication at the nano-scale. The Company is leveraging more than a decade of laser and photonics research to develop a diverse portfolio of products with commercial applications in rapidly growing industries, while continuing to carry out research and development for the U.S. Government. JMAR is targeting the nanotechnology, bioscience and semiconductor industries with its BriteLight(TM) Laser; X-ray Light Source; Compact X-ray Microscope -- for 3D visualization of single cells and polymers; and the X-ray Nano Probe -- enabling interaction, analysis and materials modification at the nano-scale. JMAR maintains a strategic alliance with FemtoTrace, a unique company applying NASA technology to trace analytical solutions, for the production of the READ chemical sensor for the homeland security, environmental and utility infrastructure industries. JMAR also manufactures and markets its series of BioSentry(TM) microorganism early-warning systems for cruise ships, municipalities, pharmaceutical and semiconductor industries.

This news release contains certain "forward-looking statements." Forward-looking statements are based on current expectations and assumptions and are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified, and many of which are beyond the Company's control. Actual results could differ materially from these forward-looking statements as a result of a number of factors, including the risk that the performance validation tests of the BioSentry Beta units are not successfully completed due to unforeseen issues with the installation and operation of the units outside of the controlled environment of JMAR's facility, delays in completion of the X-ray Microscope and X-ray Nano Probe prototypes and transition to production units, the failure of the technology to perform as predicted, competition from alternative technologies, uncertainties as to the size of the markets , cost and margins for JMAR's products, failure to obtain market acceptance, current or future government regulations affecting the use of JMAR's products, the lack of availability of critical components, the degree of protection from future patents, other risks associated with the development or acquisition of new products or technologies and those risks detailed in the Company's Form 10-K for the year ended December 31, 2005 filed with the SEC. Given these risks and uncertainties, investors are cautioned not to place undue reliance on such forward-looking statements and no assurances can be given that such statements will be achieved. JMAR Technologies, Inc. does not assume any duty to publicly update or revise the material contained herein.


JMAR Technologies, Inc.
Dennis Valentine, 858-946-6800
The Investor Relations Group
Katrine Winther-Olesen/Tom Caden, 212-825-3210

Better Be Business Wired.

Business Wire is the leading source for press releases, photos, multimedia and regulatory filings from companies and groups throughout the world.